Methoxphenidine also known as MXP is found in the family of diarylethylamine research chemical.
There is not enough data available on methoxphenidine as a supplementary chemical for any medical use at this time and therefore it is not intended for human consumption. Manufacturers use synthetic substances to create analogs of medications that are listed as controlled substances to further help scientists perform experiments on similar research chemicals with the hopes of finding alternative compounds that will benefit humans with harsh or long term side effects.
4-Me-TMP was created by research chemical manufacturers as a supplementary chemical that may be used as an alternative to methylphenidate. However, at this time, it is only for usage in a controlled laboratory setting and is not intended for human consumption. With its close relationship to methylphenidate is shown some of the same effects seen in animal drug testing. However, 4-Me-TMP is not as effective at blocking the reuptake of dopamine even though it does have a high binding affinity.
Isopropylphenidate is a newly developed research chemical which is known to be a stimulant that has a peperidine base and is related to methylphenidate.
Most cathinone’s and other analogs such as 4-MC promotes the release of serotonin, norepinephrine, and dopamine. These analogs have been studied in vivo and in-vitro using lab rats. In the synaptosomes of the brain of rats, the results showed that 4-MC released serotonin, norepinephrine, and dopamine in the brains of rats, through transporters, SERT, NET, and DAT.
3-MeO-PCE first hit the market in 2010 and can be purchased from manufacturers of research chemicals to study this new supplementary compound. This chemical is in the arylcyclohexylamine family and is known to be a hallucinogenic dissociative. The chemical properties of 3-MeO-PCE are very closely related to 3-MeO-PCP.
Etizolam is listed with research chemicals in the family of diazepines known as thienotriazolodiazepines. The creation of research chemicals by qualified manufacturers allow scientists and other industries to learn more about the way specific chemicals work in a laboratory setting. Researchers in Italy published information regarding etizolam that states that these compounds used in the creation of etizolam is easy to oxidize, metabolizes fast, and is believed to have a lower risk of accumulation.
4-CEC is a research chemical in the cathinone family created from the Catha edulis plant. Research on this supplementary compound has not been thoroughly performed. The only data available is the chemical formula, the molecular mass, and the IUPAC name. However, it is closely related to cathine, methcathinone, and certain other amphetamines. These compounds created by research chemical manufacturers release dopamine and inhibit the reuptake of norepinephrine, epinephrine, and serotonin.
3-FPM is a research chemical obtainable from manufacturers that create research chemicals as well as supplementary chemicals. 3-FPM also referred to as Pal-593 is in the phenethylamine family and is known to be a stimulant. Via studies in laboratories as well as the chemistry of 3F-Phenmetrazine the effects are not as direct as other stimulants. The studies showed that 3-fpm produces less insomnia, euphoria, and nervousness than other chemicals in the same family.
3-MEC is a supplementary research chemical created to further study mephedron substitutes. It is in the family of cathinones that are stimulants and empathogenics. Manufacturers create such research chemicals so scientists can learn more about the factors of the compounds and how they work in various experiments in controlled laboratory settings. In most cases, when studies were performed 3-MEC was compared to 4-CMC and it was noted that this new research chemical would produce serotonergic effects but it is believed it would be as potent as 4-C.
6-MAPB is a new research chemical that is known to be an entactogenic and psychedelic compound. It is related to MDMA and 6-APB structurally, therefore, it may have similar effects. Manufacturers created 6-MAPB so it could be studied to learn more about such analogs of MDA and if the new supplementary compound could produce the beneficial effects without the harmful side effects. At this time, there is only scientific research data available on this research chemical.